FDC (FDC) | Stock Overview & Key Data
FDC Performance Comparison
Stock Range
Today's Range
Low: ₹473.00
High: ₹496.75
on August 8, 2025
52 Week Range
Low: ₹366.25
High: ₹658.85
on March 3, 2025
on September 12, 2024
All-Time High: ₹658.85 on September 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR77.9B
EPS
16.38
P/E Ratio (TTM)
28.98
Forward P/E
20.37
P/B Ratio
3.38
PEG Ratio
20.37
Div. Yield
1.07%
ROE
12.19%
Beta
-0.057
Debt to Equity
0.93
Financial Highlights
Profitability
Gross Margin
67.20%
Operating Margin
7.81%
Profit Margin
12.66%
Returns and Earnings
Return on Assets (TTM)
6.54%
Return on Equity (TTM)
12.19%
EBITDA
INR4.2B
Net Income (TTM)
INR2.7B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR129.48
Quarterly Revenue Growth (YoY)
6.50%
Quarterly Earnings Growth (YoY)
-16.40%
Dividend Information
Last 12-Month Dividend
₹5.00
Current Dividend Yield
1.07%
3-Year Average Dividend Yield
0.98%
3-Year Average Annual Dividend
₹1.67
3-Year Total Dividends
₹5.00
Ex-Dividend Date
November 22, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| FDC FDC | 77.88B Mid-cap | -0.16% | -6.34% | 10.62% | 3.05% | -7.13% | -2.97% | 79.21% | 46.63% |
| Sun Pharmaceutical SUNPHARMA | 3.84T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.57T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Alembic APLLTD | 184.02B Mid-cap | -2.38% | -6.43% | 3.77% | 5.42% | -10.75% | -17.18% | 43.48% | -9.82% |
| Jubilant Pharmova JUBLPHARMA | 174.95B Mid-cap | -5.02% | -5.59% | 24.87% | 10.08% | 1.88% | 27.78% | 214.12% | 81.50% |
| Natco Pharma NATCOPHARM | 162.72B Mid-cap | -2.50% | -7.83% | 13.12% | -29.19% | -35.03% | -36.97% | 40.23% | 9.43% |
Ownership & Short Interest
Insider Ownership
69.66%
Institutional Ownership
7.46%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
103K
Average 90-Day Volume
140K
FDC Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in FDC would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is FDC's 52-week high and low?
- In the last 52 weeks, FDC reached a high of ₹658.85 (on September 12, 2024) and a low of ₹366.25 (on March 3, 2025).
- What is the market cap and P/E ratio for FDC?
- Curious about FDC's size and valuation? Its market capitalization stands at 77.88B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.98, and the forward P/E (looking ahead) is 20.37.
- Does FDC pay dividends? If so, what's the yield?
- Yes, FDC is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.07%, and the company has paid an average of ₹1.67 per share annually over the past 3 years.
- Who are FDC's main competitors or similar companies to consider before investing?
When looking at FDC, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.84T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.57T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Alembic
APLLTD184.02B Healthcare Drug Manufacturers - Specialty & Generic -17.18% 43.48% Jubilant Pharmova
JUBLPHARMA174.95B Healthcare Drug Manufacturers - Specialty & Generic 27.78% 214.12% Natco Pharma
NATCOPHARM162.72B Healthcare Drug Manufacturers - Specialty & Generic -36.97% 40.23% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for FDC Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of FDC's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.19%, the Debt to Equity ratio from the most recent quarter is 0.93, and its Gross Profit Margin stands at 67.20%.
- What is the recent revenue and earnings growth for FDC?
- Looking at FDC's growth, its revenue over the trailing twelve months (TTM) was INR21B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.50%, and quarterly earnings saw a YoY growth of -16.40%.
- How much of FDC stock is held by insiders and institutions?
- Wondering who owns FDC stock? Company insiders (like executives and directors) hold about 69.66% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.46%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.